Arianna Granese

Rome, 00185, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Novel Insights on Benzo[b]thiophene Analogues for MAO-B Inhibition and Neuroprotection: Design, Synthesis, Molecular Modelling Studies and Biological Activity.

Novel Insights on Benzo[b]thiophene Analogues for MAO-B Inhibition and Neuroprotection: Design, Synthesis, Molecular Modelling Studies and Biological Activity.

Journal: Antioxidants (Basel, Switzerland)

Published: January 12, 2026

Design, synthesis, molecular modelling investigation and biological studies of novel human carbonic anhydrase inhibitors based on coumalic acid.

Design, synthesis, molecular modelling investigation and biological studies of novel human carbonic anhydrase inhibitors based on coumalic acid.

Journal: RSC medicinal chemistry

Published: March 09, 2025

Development of N-(4-(1H-Imidazol-1-yl)phenyl)-4-chlorobenzenesulfonamide, a Novel Potent Inhibitor of β-Catenin with Enhanced Antitumor Activity and Metabolic Stability.

Development of N-(4-(1H-Imidazol-1-yl)phenyl)-4-chlorobenzenesulfonamide, a Novel Potent Inhibitor of β-Catenin with Enhanced Antitumor Activity and Metabolic Stability.

Journal: Journal of medicinal chemistry

Published: November 07, 2024

Drug design of tyrosinase inhibitors.

Drug design of tyrosinase inhibitors.

Journal: The Enzymes

Published: September 20, 2024

Recent trends and challenges to overcome Pseudomonas aeruginosa infections.

Recent trends and challenges to overcome Pseudomonas aeruginosa infections.

Journal: Expert opinion on therapeutic patents

Published: April 29, 2024

Peroxisome Proliferator-Activated Receptor agonists and antagonists: an updated patent review (2020-2023).

Peroxisome Proliferator-Activated Receptor agonists and antagonists: an updated patent review (2020-2023).

Journal: Expert opinion on therapeutic patents

Published: March 19, 2024

Recent developments of agents targeting Vibrio cholerae: patents and literature data.

Recent developments of agents targeting Vibrio cholerae: patents and literature data.

Journal: Expert opinion on therapeutic patents

Published: March 06, 2024

Novel therapeutic opportunities for Toxoplasma gondii, Trichomonas vaginalis, and Giardia intestinalis infections.

Novel therapeutic opportunities for Toxoplasma gondii, Trichomonas vaginalis, and Giardia intestinalis infections.

Journal: Expert opinion on therapeutic patents

Published: April 26, 2023

A Novel Class of Dual-Acting DCH-CORMs Counteracts Oxidative Stress-Induced Inflammation in Human Primary Tenocytes.

A Novel Class of Dual-Acting DCH-CORMs Counteracts Oxidative Stress-Induced Inflammation in Human Primary Tenocytes.

Journal: Antioxidants (Basel, Switzerland)

Published: October 14, 2021

Synthesis and Evaluation of Thymol-Based Synthetic Derivatives as Dual-Action Inhibitors against Different Strains of H. pylori and AGS Cell Line.

Synthesis and Evaluation of Thymol-Based Synthetic Derivatives as Dual-Action Inhibitors against Different Strains of H. pylori and AGS Cell Line.

Journal: Molecules (Basel, Switzerland)

Published: March 07, 2021

Antimicrobial activity, synergism and inhibition of germ tube formation by Crocus sativus-derived compounds against Candida spp.

Antimicrobial activity, synergism and inhibition of germ tube formation by Crocus sativus-derived compounds against Candida spp.

Journal: Journal of enzyme inhibition and medicinal chemistry

Published: May 11, 2016

(Thiazol-2-yl)hydrazone derivatives from acetylpyridines as dual inhibitors of MAO and AChE: synthesis, biological evaluation and molecular modeling studies.

(Thiazol-2-yl)hydrazone derivatives from acetylpyridines as dual inhibitors of MAO and AChE: synthesis, biological evaluation and molecular modeling studies.

Journal: Journal of enzyme inhibition and medicinal chemistry

Published: March 26, 2015

Showing 1-12 of 14

Last Updated: 09/26/2026